Revenues of Dare Bioscience, Inc. from 31 Dec 2012 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Dare Bioscience, Inc. quarterly and annual Revenues in USD history and change rate from 31 Dec 2012 to 30 Sep 2024.
  • Dare Bioscience, Inc. Revenues for the quarter ending 30 Sep 2024 was $41,691, a 96% decline year-over-year.
  • Dare Bioscience, Inc. Revenues for the twelve months ending 30 Sep 2024 was $1,881,316.
  • Dare Bioscience, Inc. annual Revenues for 2023 was $2,807,885, a 72% decline from 2022.
  • Dare Bioscience, Inc. annual Revenues for 2022 was $10,000,000.
  • Dare Bioscience, Inc. annual Revenues for 2021 was $0.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Dare Bioscience, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,881,316 $41,691 -$958,309 -96% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $2,839,625 $22,438 +$22,438 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $2,817,187 $9,302 +$9,302 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $2,807,885 $1,807,885 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q3 2023 $1,000,000 +$1,000,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $0 -$10,000,000 -100% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $0 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q3 2022 $0 $0 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $10,000,000 +$10,000,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q2 2017 $642,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $1,192,000 01 Jan 2017 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 $766,000 01 Oct 2016 31 Dec 2016 10-K/A 13 Jun 2017 2016 FY
Q1 2015 $0 -$47,000 -100% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q2 2014 $33,000 01 Apr 2014 30 Jun 2014 10-K 10 Mar 2016 2015 FY
Q1 2014 $47,000 01 Jan 2014 31 Mar 2014 10-K 10 Mar 2016 2015 FY
Q4 2013 $6,000 01 Oct 2013 31 Dec 2013 10-K 19 Mar 2015 2014 FY

Dare Bioscience, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $2,807,885 -$7,192,115 -72% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 $10,000,000 +$10,000,000 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2016 $766,000 01 Jan 2016 31 Dec 2016 10-K/A 13 Jun 2017 2016 FY
2014 $80,000 +$74,000 +1233% 01 Jan 2014 31 Dec 2014 10-K/A 13 Jun 2017 2016 FY
2013 $6,000 -$619,000 -99% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $625,000 01 Jan 2012 31 Dec 2012 10-K 19 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.